A
COMPARATIVE
STUDY
OF
TICARCILLIN
PLUS
TOBRAMYCIN
VERSUS
CARBENICILLIN
PLUS
GENTAMICIN
FOR
THE
TREATMENT
OF
SERIOUS
INFECTIONS
DUE
TO
GRAMNEGATIVE
BACILLI
THE
COMBINATION
OF
TICARCILLIN
PLUS
TOBRAMYCIN
TT
OR
CARBENICILLIN
PLUS
GENTAMICIN
CG
WAS
USED
TO
TREAT
82
PATIENTS
WITH
SEVERE
SYSTEMIC
GRAMNEGATIVE
INFECTION
IN
A
PROSPECTIVE
RANDOMIZED
STUDY
PSEUDOMONAS
AERUGINOSA
WAS
THE
PRIMARY
PATHOGEN
IN
7
93
PER
CENT
OF
THESE
PATIENTS
PATIENTS
TREATED
WITH
TT
RESPONDED
MORE
FREQUENTLY
92
PER
CENT
OR
37
OF
40
THAN
PATIENTS
TREATED
WITH
CG
71
PER
CENT
OR
30
OF
42
P
IS
LESS
THAN
005
THIS
DIFFERENCE
WAS
PRIMARILY
DUE
TO
A
GREATER
RESPONSE
TO
TT
IN
PATIENTS
WITH
PULMONARY
INFECTIONS
93
PER
CENT
VERSUS
68
PER
CENT
AND
INFECTIONS
DUE
TO
PSEUDOMONAS
92
PER
CENT
VERSUS
70
PER
CENT
SEVERITY
OF
UNDERLYING
DISEASE
WAS
ALSO
AN
IMPORTANT
DETERMINANT
OF
RESPONSE
EXCEPT
FOR
A
GREATER
INCIDENCE
OF
HEPATOTOXICITY
WITH
CG
23
PER
CENT
VERSUS
3
PER
CENT
P
IS
LESS
THAN
002
THERE
WAS
NO
DIFFERENCE
IN
TOXICITY
COLONIZATION
WITH
DRUGRESISTANT
MICROORGANISMS
OR
SUPERINFECTION
BETWEEN
THE
TWO
TREATMENT
GROUPS
THE
COMBINATION
OF
TT
APPEARS
TO
BE
SUPERIOR
TO
CG
FOR
THE
TREATMENT
OF
PULMONARY
INFECTIONS
DUE
TO
PSEUDOMONAS
AERUGINOSA
